Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 12 July, 2019

Citadel Group

Form 8.3 - Allergan PLC

RNS Number : 3925F
Citadel Group
12 July 2019
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap 19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.         KEY INFORMATION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

 

Date of dealing

11 July, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security

                    dealt in (Note 3)

 

 

 

 

 

 

Long

Short

Common Stock  ISIN  IE00BY9D5467

Number        (%)

Number      (%)

(1) Relevant securities

2,764,188 (0.84%)

208 (0.00%)

(2) Derivatives (other than options)

852,990 (0.26%)

0 (0.00%)

(3) Options and agreements to purchase/sell

500,000 (0.15%)

0 (0.00%)

Total

4,117,178(1.25%)

208 (0.00%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long

Short

 

Number        (%)

Number      (%)

(1) Relevant securities

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap 20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.         DEALINGS (Note 4)

 

(a)        Purchases and sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase/sale

Common Stock ISIN IE00BY9D5467

Number of securities

Price per unit (Note 5)

a buy

1,725

165.97  USD

a sell

-1,725

165.97  USD

Purchase

100

165.48  USD

Purchase

197

165.53  USD

Purchase

200

165.54  USD

Purchase

200

165.55  USD

Purchase

50

165.59  USD

Purchase

100

165.66  USD

Purchase

100

165.72  USD

Purchase

700

165.737143  USD

Purchase

155

165.74  USD

Purchase

200

165.745  USD

Purchase

144

165.75  USD

Purchase

448

165.752411  USD

Purchase

100

165.755  USD

Purchase

194

165.76  USD

Purchase

300

165.773333  USD

Purchase

1,500

165.803333  USD

Purchase

1,100

165.805  USD

Purchase

730

165.808288  USD

Purchase

299

165.81  USD

Purchase

1,870

165.817225  USD

Purchase

300

165.82  USD

Purchase

200

165.83  USD

Purchase

5,800

165.838448  USD

Purchase

165

165.84  USD

Purchase

2,300

165.846087  USD

Purchase

300

165.86  USD

Purchase

129

165.87  USD

Purchase

57

165.89  USD

Purchase

200

165.95  USD

Purchase

400

165.96  USD

Purchase

663

165.97  USD

Purchase

200

165.98  USD

Purchase

199

165.99  USD

Purchase

298

166  USD

Purchase

100

166.015  USD

Purchase

300

166.03  USD

Purchase

200

166.05  USD

Purchase

4

166.06  USD

Purchase

317

166.07  USD

Purchase

600

166.08  USD

Purchase

100

166.085  USD

Purchase

700

166.09  USD

Purchase

100

166.095  USD

Purchase

400

166.1  USD

Purchase

100

166.105  USD

Purchase

897

166.11  USD

Purchase

100

166.115  USD

Purchase

980

166.12  USD

Purchase

762

166.13  USD

Purchase

710

166.14  USD

Purchase

603

166.15  USD

Purchase

200

166.16  USD

Purchase

7

166.165  USD

Purchase

1,781

166.17  USD

Purchase

829

166.18  USD

Purchase

1,339

166.19  USD

Purchase

100

166.195  USD

Purchase

459

166.2  USD

Purchase

100

166.205  USD

Purchase

530

166.21  USD

Purchase

142

166.215  USD

Purchase

500

166.22  USD

Purchase

225

166.23  USD

Purchase

8

166.24  USD

Purchase

30

166.25  USD

Purchase

192

166.26  USD

Purchase

289

166.27  USD

Purchase

100

166.28  USD

Purchase

100

166.29  USD

Purchase

215

166.3  USD

Purchase

37

166.32  USD

Purchase

100

166.37  USD

Purchase

762

166.38  USD

Purchase

10

166.39  USD

Purchase

70

166.4  USD

Purchase

200

166.41  USD

Purchase

103

166.43  USD

Purchase

200

166.46  USD

Purchase

68

166.47  USD

Purchase

1,200

166.5  USD

Purchase

200

166.65  USD

Purchase

158

166.66  USD

Purchase

406

166.75  USD

Purchase

400

166.76  USD

Purchase

330

166.77  USD

Purchase

100

166.82  USD

Purchase

300

166.83  USD

Purchase

100

166.84  USD

Purchase

242

166.85  USD

Purchase

185

166.86  USD

Purchase

200

166.91  USD

Purchase

100

166.93  USD

Purchase

650

166.94  USD

Purchase

200

166.95  USD

Purchase

357

166.96  USD

Purchase

500

166.97  USD

Purchase

300

166.98  USD

Purchase

2

166.99  USD

Purchase

513

167  USD

Purchase

328

167.02  USD

Purchase

110

167.03  USD

Purchase

100

167.04  USD

Sale

-100

165.69  USD

Sale

-200

165.71  USD

Sale

-56

165.72  USD

Sale

-100

165.8  USD

Sale

-200

165.81  USD

Sale

-257

165.82  USD

Sale

-100

165.83  USD

Sale

-100

165.89  USD

Sale

-100

165.9  USD

Sale

-200

165.91  USD

Sale

-200

165.92  USD

Sale

-137

165.94  USD

Sale

-32

165.944375  USD

Sale

-175

165.947314  USD

Sale

-51

165.94902  USD

Sale

-200

165.95  USD

Sale

-6,050

165.97  USD

Sale

-100

165.98  USD

Sale

-26

166.004231  USD

Sale

-132

166.009167  USD

Sale

-51

166.01  USD

Sale

-459

166.010458  USD

Sale

-84

166.012381  USD

Sale

-154

166.01974  USD

Sale

-145

166.02  USD

Sale

-38

166.02  USD

Sale

-100

166.025  USD

Sale

-344

166.03  USD

Sale

-200

166.05  USD

Sale

-324

166.07  USD

Sale

-200

166.08  USD

Sale

-239

166.09  USD

Sale

-1,788

166.1  USD

Sale

-345

166.11  USD

Sale

-565

166.12  USD

Sale

-634

166.13  USD

Sale

-200

166.14  USD

Sale

-945

166.15  USD

Sale

-600

166.16  USD

Sale

-735

166.17  USD

Sale

-27

166.171111  USD

Sale

-158

166.174494  USD

Sale

-46

166.175217  USD

Sale

-400

166.18  USD

Sale

-668

166.19  USD

Sale

-508

166.2  USD

Sale

-431

166.21  USD

Sale

-133

166.22  USD

Sale

-136

166.23  USD

Sale

-303

166.24  USD

Sale

-82

166.27  USD

Sale

-100

166.3  USD

Sale

-100

166.34  USD

Sale

-105

166.35  USD

Sale

-100

166.375  USD

Sale

-200

166.38  USD

Sale

-116

166.39  USD

Sale

-382

166.4  USD

Sale

-510

166.41  USD

Sale

-482

166.42  USD

Sale

-439

166.43  USD

Sale

-186

166.44  USD

Sale

-968

166.45  USD

Sale

-200

166.47  USD

Sale

-500

166.5  USD

Sale

-100

166.6  USD

Sale

-103

166.63  USD

Sale

-100

166.64  USD

Sale

-32

166.65  USD

Sale

-37

166.67  USD

Sale

-84

166.69  USD

Sale

-400

166.7  USD

Sale

-467

166.71  USD

Sale

-479

166.72  USD

Sale

-966

166.74  USD

Sale

-350

166.75  USD

Sale

-201

166.76  USD

Sale

-126

166.77  USD

Sale

-62

166.78  USD

Sale

-100

166.79  USD

Sale

-31

166.81  USD

Sale

-376

166.83  USD

Sale

-131

166.84  USD

Sale

-75

166.85  USD

Sale

-379

166.86  USD

Sale

-200

166.88  USD

Sale

-370

166.89  USD

Sale

-600

166.91  USD

Sale

-34

166.94  USD

Sale

-253

166.95  USD

Sale

-980

166.96  USD

Sale

-147

166.97  USD

Sale

-100

166.98  USD

Sale

-100

167  USD

Sale

-200

167.02  USD

Sale

-300

167.03  USD

Sale

-100

167.07  USD

Sale

-200

167.08  USD

Sale

-400

167.23  USD

Sale

-100

167.25  USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b)        Derivatives transactions (other than options transactions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product name,

e.g. CFD

Common Stock ISIN IE00BY9D5467

Nature of transaction

(Note 6)

 

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Increasing long position

244,045

166.338824  USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(c)        Options transactions in respect of existing relevant securities

 

(i)         Writing, selling, purchasing or varying

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product name, e.g. call option

Writing, selling, purchasing,

varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type,e.g. American, European etc.

Expiry date

Option money paid/ received per unit (Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)        Exercising

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product name,

e.g. call option

Number of securities

Exercise price per unit

(Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nature of transaction

(Note 8)

      Details

      Price per unit

      (if applicable) (Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap 21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2.         OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated

None

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)

 

 

YES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Date of disclosure:

12 July, 2019

 Contact name:

Katie Bonds

 Telephone number:

020 7743 9437

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a

 

 

 

 

 

 

 

 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

 

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Put Option

Written

 500,000

160 USD

American

08/16/2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes

 

1.          Where there are open option positions or open derivative positions (except for CFDs), full details should be given. 

Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEDMGMNLZFGLZG

a d v e r t i s e m e n t